Quick Answer
ADAPTIN BIO, INC. reported Net Income Loss of -$161.2 thousand for the year ending 2024.
- ADAPTIN BIO, INC. showed a decrease of -88.3% in Net Income Loss from 2023 to 2024.
- This data is from ADAPTIN BIO, INC.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2023 to 2024 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: -$15.1 thousand | Q2 2022: -$4.3 thousand | Q3 2022: -$4.3 thousand | Q1 2023: -$4.3 thousand | Q2 2023: -$4.3 thousand | Q3 2023: -$42.9 thousand | Q1 2024: -$339.4 thousand | Q2 2024: -$818.7 thousand | Q3 2024: -$1.11 million | Q1 2025: -$603.1 thousand | Q2 2025: -$1.52 million | Q3 2025: -$1.68 million.
- Historical annual values: Fiscal year 2024: -$161.2 thousand | Fiscal year 2023: -$85.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: